{"id":13630,"date":"2025-11-21T06:00:00","date_gmt":"2025-11-21T11:00:00","guid":{"rendered":"https:\/\/cov19longhaulfoundation.org\/?p=13630"},"modified":"2025-10-22T09:00:37","modified_gmt":"2025-10-22T13:00:37","slug":"neuroinflammatory-and-glutamatergic-dysregulation-in-long-covid-framework-for-treating-brain-fog-confusion-and-depression","status":"publish","type":"post","link":"https:\/\/cov19longhaulfoundation.org\/?p=13630","title":{"rendered":"Neuroinflammatory and Glutamatergic Dysregulation in Long COVID: Treating Brain Fog, Confusion, and Depression"},"content":{"rendered":"\n

John Murphy, \u2013 President, COVID-19 Long-haul Foundation<\/em><\/p>\n\n\n\n

Pathophysiology of Long COVID Neurocognitive Sequelae<\/strong><\/h2>\n\n\n\n

Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is increasingly recognized as a chronic, multisystemic condition with a prominent neuropsychiatric component. Among its most disabling symptoms are cognitive dysfunction (\u201cbrain fog\u201d), confusion, and depression. These symptoms are not merely psychosomatic but are now understood to have a measurable biological basis.<\/p>\n\n\n\n

Recent PET imaging studies from Yokohama City University have identified a significant increase in AMPA receptor density across multiple cortical regions in long COVID patients, suggesting a hyperglutamatergic state that may underlie cognitive overload and excitotoxicity. This receptor upregulation is associated with impaired executive function, working memory deficits, and attentional dysregulation\u2014hallmarks of long COVID brain fog.<\/p>\n\n\n\n

Complementary findings from Michigan State University and Corewell Health demonstrate elevated levels of pro-inflammatory cytokines (e.g., IL-6, TNF-\u03b1) and stress hormones (e.g., cortisol) in the cerebrospinal fluid of long COVID patients with persistent cognitive symptoms. These biomarkers point to a sustained neuroinflammatory state, potentially driven by microglial activation and blood-brain barrier disruption.<\/p>\n\n\n\n

MRI studies have further corroborated these findings. A 2024 cross-sectional analysis from Argentina revealed structural changes in the hippocampus and prefrontal cortex, with reduced gray matter volume and altered white matter integrity in long COVID patients two years post-infection.<\/p>\n\n\n\n

Clinical Manifestations: Brain Fog, Confusion, and Depression<\/strong><\/h2>\n\n\n\n

The neurocognitive symptoms of long COVID are heterogeneous but often include:<\/p>\n\n\n\n

    \n
  • Brain fog<\/strong>: Difficulty with concentration, memory, and multitasking<\/li>\n\n\n\n
  • Confusion<\/strong>: Disorientation, slowed processing, and executive dysfunction<\/li>\n\n\n\n
  • Depression<\/strong>: Anhedonia, fatigue, and emotional dysregulation<\/li>\n<\/ul>\n\n\n\n

    These symptoms can persist for months or years, even in patients who experienced only mild acute COVID-19. In a 2024 CDC survey, approximately 7% of U.S. adults reported long COVID symptoms, with nearly half citing cognitive impairment as a primary concern.<\/p>\n\n\n\n

    Clinicians at Yale Medicine\u2019s NeuroCOVID Clinic have observed that many patients with long COVID-related brain fog exhibit patterns similar to those seen in post-concussive syndrome and ADHD, including impaired working memory and attentional control. These overlaps have informed emerging therapeutic strategies.<\/p>\n\n\n\n

    Therapeutic Strategies: Pharmacologic and Integrative Approaches<\/strong><\/h2>\n\n\n\n

    1. Guanfacine + N-Acetylcysteine (NAC)<\/strong><\/h3>\n\n\n\n

    A promising pharmacologic approach involves the synergistic use of guanfacine<\/strong>, an \u03b12A-adrenergic agonist, and N-acetylcysteine (NAC)<\/strong>, a glutathione precursor and antioxidant. This regimen was pioneered by Yale researchers Drs. Amy Arnsten and Arman Fesharaki-Zadeh, who observed that guanfacine strengthens prefrontal cortical circuits while NAC reduces oxidative stress and neuroinflammation.<\/p>\n\n\n\n

    In a 2023 case series, 8 of 12 patients treated with this combination reported substantial improvements in memory, executive function, and daily functioning. The regimen typically involved 1\u20132 mg of guanfacine extended-release at bedtime and 600 mg of NAC daily. Side effects were minimal and manageable.<\/p>\n\n\n\n

    2. Cognitive Rehabilitation<\/strong><\/h3>\n\n\n\n

    Structured cognitive rehabilitation programs, including digital platforms like BrainHQ and Lumosity, are being used to retrain executive function and memory. Speech-language pathologists and neuropsychologists at Yale New Haven Health have developed metacognitive tracking tools to help patients monitor symptom patterns and cognitive load.<\/p>\n\n\n\n

    3. Psychotherapeutic Support<\/strong><\/h3>\n\n\n\n

    Given the overlap with trauma and chronic illness, many patients benefit from:<\/p>\n\n\n\n

      \n
    • Cognitive Behavioral Therapy (CBT)<\/strong> for mood and behavior regulation<\/li>\n\n\n\n
    • Acceptance and Commitment Therapy (ACT)<\/strong> for coping with uncertainty<\/li>\n\n\n\n
    • Mindfulness-based interventions<\/strong> to reduce stress and improve focus<\/li>\n<\/ul>\n\n\n\n

      These approaches are often integrated with physical and occupational therapy in long COVID clinics.<\/p>\n\n\n\n

      4. Lifestyle and Adjunctive Measures<\/strong><\/h3>\n\n\n\n
        \n
      • Exercise<\/strong>: Carefully titrated aerobic activity can improve cognition but must be paced to avoid post-exertional malaise, especially in patients with ME\/CFS-like symptoms.<\/li>\n\n\n\n
      • Sleep hygiene<\/strong>: Addressing comorbid sleep apnea or insomnia is critical.<\/li>\n\n\n\n
      • Nutritional support<\/strong>: Omega-3s, B-vitamins, and anti-inflammatory diets are under investigation.<\/li>\n<\/ul>\n\n\n\n

        Diagnostic Frameworks and Biomarker Panels<\/strong><\/h2>\n\n\n\n

        There is currently no single diagnostic test for long COVID brain fog. However, a multimodal approach is emerging:<\/p>\n\n\n\n

          \n
        • Neurocognitive testing<\/strong>: Assessments of working memory, attention, and executive function<\/li>\n\n\n\n
        • Neuroimaging<\/strong>: PET and MRI to detect AMPA receptor density and structural changes<\/li>\n\n\n\n
        • Biomarkers<\/strong>: Serum cytokines, cortisol, and glutamate levels<\/li>\n<\/ul>\n\n\n\n

          Future diagnostic panels may integrate these modalities to stratify patients and guide personalized therapy.<\/p>\n\n\n\n

          Case Studies and Patient Stratification<\/strong><\/h2>\n\n\n\n

          In clinical practice, patient responses to treatment vary based on:<\/p>\n\n\n\n

            \n
          • Severity and duration<\/strong> of initial infection<\/li>\n\n\n\n
          • Pre-existing conditions<\/strong> (e.g., ADHD, depression, autoimmune disease)<\/li>\n\n\n\n
          • Neuroimaging findings<\/strong> (e.g., AMPA receptor density, hippocampal atrophy)<\/li>\n<\/ul>\n\n\n\n

            One illustrative case involved a 38-year-old ICU nurse with severe brain fog post-COVID. After initiating guanfacine and NAC, she reported restored cognitive clarity and returned to full-time work within six weeks.<\/p>\n\n\n\n

            Future Directions and Research Gaps<\/strong><\/h2>\n\n\n\n

            To advance care and understanding, we recommend:<\/p>\n\n\n\n

              \n
            1. Randomized controlled trials<\/strong> of guanfacine + NAC in diverse populations<\/li>\n\n\n\n
            2. Development of biomarker-guided diagnostic algorithms<\/strong><\/li>\n\n\n\n
            3. Longitudinal studies<\/strong> on cognitive recovery trajectories<\/li>\n\n\n\n
            4. Exploration of gut-brain axis and viral persistence<\/strong> as contributing factors<\/li>\n\n\n\n
            5. Integration of wearable neurocognitive monitoring tools<\/strong> for real-time assessment<\/li>\n<\/ol>\n\n\n\n

              Conclusion<\/strong><\/h2>\n\n\n\n

              Long COVID\u2013associated brain fog, confusion, and depression are biologically grounded, measurable, and increasingly treatable. The convergence of neuroimaging, biomarker research, and clinical innovation has opened new therapeutic avenues. A systems-based approach\u2014combining pharmacologic, cognitive, and psychosocial strategies\u2014offers the most promise for restoring function and quality of life in affected individuals.<\/p>\n\n\n\n

              The COVID-19 Long-haul Foundation remains committed to accelerating research, refining diagnostics, and disseminating evidence-based care models to address this urgent public health challenge.<\/p>\n\n\n\n

              References<\/strong><\/h2>\n\n\n\n
                \n
              1. Schreiber M. Treating patients with long COVID<\/em>. APA Monitor. 2024. Link<\/li>\n\n\n\n
              2. Katella K. Long COVID Brain Fog: What It Is and How to Manage It<\/em>. Yale Medicine. 2024. Link<\/li>\n\n\n\n
              3. Backman I. Potential New Treatment for \u201cBrain Fog\u201d in Long COVID Patients<\/em>. Yale School of Medicine. 2022. Link<\/li>\n\n\n\n
              4. YCU Advanced Medical Research Center. Scientists finally reveal what\u2019s behind long COVID\u2019s mysterious brain fog<\/em>. ScienceDaily. 2025. Link<\/li>\n\n\n\n
              5. Scientists Finally Reveal Biological Basis of Long COVID Brain Fog<\/em>. SciTechDaily. 2025. Link<\/li>\n\n\n\n
              6. MSU\/Corewell Health. Link Between Brain Fog and Long COVID<\/em>. Michigan State University. 2025. Link<\/li>\n\n\n\n
              7. Cataldo SA et al. Cognitive impact and brain structural changes in long COVID patients<\/em>. BMC Neurology. 2024. Link<\/li>\n\n\n\n
              8. Ocklenburg S. Brain Fog in Long COVID Linked to Increase in AMPA Receptors<\/em>. Psychology Today. 2025. Link<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                John Murphy, \u2013 President, COVID-19 Long-haul Foundation Pathophysiology of Long COVID Neurocognitive Sequelae Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is increasingly recognized as a chronic, multisystemic condition […]<\/p>\n","protected":false},"author":2,"featured_media":13643,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59,762,113,252,364,368],"tags":[],"class_list":["post-13630","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-brain-fog","category-confusion","category-depression-mental-health","category-inflammation","category-neuroinflammation","category-neuropathy"],"_links":{"self":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/13630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13630"}],"version-history":[{"count":3,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/13630\/revisions"}],"predecessor-version":[{"id":13641,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/13630\/revisions\/13641"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/media\/13643"}],"wp:attachment":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}